Patent · US Active

2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia

US7863265B2 · kind B2 · utility

0Cited by

6References

2Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Susanne Alenfalk · Mölndal, SE
Mikael Dahlstrom · Timrå, SE
Fana Hunegnaw · Mölndal, SE
Staffan Po Karlsson · Mölndal, SE
Malin Lemurell · Mölndal, SE
Ann-Margret Lindqvist · Timrå, SE
Tore Skjaret · Hultsfred, SE
Ingemar Starke · Gothenburg, SE

Key dates

Filing date	Jun 19, 2006
Grant date	Jan 4, 2011
Priority date	—
Expiry date	Sep 28, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/06026
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.